86 Followers on Owler

Repligen

is a Massachusetts-based global life sciences company that develops bioprocessing technologies and systems for biopharmaceutical drug developers and CDMOs... Read more

Overview Competitors Acquisitions Funding News & Insights

Repligen

is a Massachusetts-based global life sciences company that develops bioprocessing technologies and systems for biopharmaceutical drug developers and CDMOs... Read more

President & CEO

Olivier Loeillot

CEO Approval Rating

82/100

1981

WalthamMassachusetts

PublicIndependent CompanyNASDAQRGEN

Pharmaceuticals & Biotechnology

28342836 NAICS listing

https://www.repligen.com/

Annual Revenue

$634.4M

Employees

2,020

News

Repligen acquired 908 Devices’s Desktop Portfolio of Four Devices For Bioprocessing Process Analytical Technology for undisclosed amount

Conference Presentation

Repligen Corporation to Present at 43rd Annual J.P. Morgan Healthcare Conference

Repligen Launches the CTech SoloVPE PLUS System

Repligen Announces Publication of the Company's 2023 Corporate Sustainability Report

Leadership Change

Olivier Loeillot is now President & CEO at Repligen

Repligen Competitors

1

2

3

4

5

6

7

8

9

10

Unlock 26 + competitors

Trending Companies